Adults 6 to 18, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change in Cosine Similarity of the Muscle Synergies of the Most Affected Lower LimbPrimary· Data collected at baseline and at completion of the 7-week intervention
Surface electromyographic (EMG) data collected from 16 muscles of the lower limbs during overground gait will be analyzed using the non-negative matrix factorization technique to quantify the patterns of co-activation of muscles. Cosine similarity values will be estimated for the EMG recordings collected pre- and post-intervention. Cosine similarity values will range between 0 and 1, where 1 means that the patterns of co-activation are identical to normative whereas 0 means that they are completely different (as they do not overlap). The percentage of muscle synergies displaying an increase in
Group
Value
95% CI
Robot-assisted Gait Training
2
± 6
Change in Gross Motor Function Measure (GMFM) Dimension DSecondary· Data collected at baseline and at completion of the 7-week intervention
The GMFM Dimension D consists of a battery of thirteen motor tasks that the rater evaluates via visual observation of the motor behavior of the study participant. Dimension D of the scale is focused on standing function. Each item is scored on a 4-point ordinal scale from 0 to 3, where 0 indicates that the participant does not initiate the task; 1 indicates that the participant initiates the task; 2 indicates that the participant partially completes the task; and 3 indicates that the participant completes the task. The minimum value is 0, and the maximum value is 39. Higher values represent be
Group
Value
95% CI
Robot-assisted Gait Training
5.9
± 8.1
Change in Gross Motor Function Measure (GMFM) Dimension ESecondary· Data collected at baseline and at completion of the 7-week intervention
The GMFM Dimension E consists of a battery of twenty-four motor tasks that the rater evaluates via visual observation of the motor behavior of the study participant. Dimension E of the scale is focused on walking function. Each item is scored on a 4-point ordinal scale from 0 to 3, where 0 indicates that the participant does not initiate the task; 1 indicates that the participant initiates the task; 2 indicates that the participant partially completes the task; and 3 indicates that the participant completes the task. The minimum value is 0, and the maximum value is 72. Higher values represent
Group
Value
95% CI
Robot-assisted Gait Training
10.0
± 9.3
Percent Change in 10-Meter Walk TestSecondary· Data collected at baseline and at completion of the 7-week intervention
Study staff will use a stopwatch to measure the time needed by study participants to cover a distance of 10 meters.
Group
Value
95% CI
Robot-assisted Gait Training
-0.8
± 28.0
Percent Change in 6-Minutes Walk TestSecondary· Data collected at baseline and at completion of the 7-week intervention
Study staff will measure the distance walked by study participants during an interval of 6 min.
Group
Value
95% CI
Robot-assisted Gait Training
23.5
± 37.7
Percent Change in Edinburgh Visual Gait Scores (EVGS)Secondary· Data collected at baseline and at completion of the 7-week intervention
The EVGS score is a standardized measure of gait quality derived using criteria based on visual observation of gait patterns in children with cerebral palsy. The EVGS includes 17 gait parameters and uses a three-point ordinal scale for each parameter, corresponding to normal, moderate, and severe deviation, respectively. The total score range is from 0 to 34 points, where 0 corresponds to normal gait and greater than 0 indicates gait abnormality.
Group
Value
95% CI
Robot-assisted Gait Training
16.7
± 12.7
Sponsor's own description
This is a single-arm longitudinal study for children with cerebral palsy with gait impairments that involves robot-assisted gait training (RGT) and includes pre and post-data collection visits. The study aims to evaluate changes in muscle synergies in children with Cerebral Palsy (CP) in response to RGT. Additionally, the study aims to investigate the relationship between muscle synergies and the clinical outcomes of RGT.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa
· NA
· recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy
· active not recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes
· recruiting
NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy
· NA
· recruiting
Other Spaulding Rehabilitation Hospital trials
Trials by the same sponsor.
NCT04940403 — BurtVision™ for Arm Rehabilitation in Chronic Stroke Survivors:
· NA
· not yet recruiting
NCT06193317 — Effects of taVNS on Fibromyalgia Pain
· NA
· not yet recruiting
NCT07483320 — Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy
· NA
· not yet recruiting
NCT06797154 — A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Subacute Stroke Survivors
· NA
· recruiting
NCT06826781 — Evaluating Q-Collar Effects on Brain Blood Flow Control During Exercise
· NA
· recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Spaulding Rehabilitation Hospital
Last refreshed: 19 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06156969.